TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs
Can't see this email? View it online
   
  October 15, 2017  
  Tuberculosis  
  The latest tuberculosis news from News Medical  
 TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugsTB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs
 
TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.
 
 
 Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected peopleTrial reveals value of tuberculosis chemoprophylaxis in HIV-infected people
 
Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.
 
   NIH awards $2.3 million grant to Umass Amherst microbiologist for TB researchNIH awards $2.3 million grant to Umass Amherst microbiologist for TB research
 
The National Institutes of Health announced today that microbiologist Sloan Siegrist at the University of Massachusetts Amherst has received a five-year, $2.3 million National Institutes of Health New Innovator Award, which supports "unusually innovative research from early career investigators," to study the bacterium that causes tuberculosis (TB).
 
   Study finds no association between BCG vaccine and childhood asthmaStudy finds no association between BCG vaccine and childhood asthma
 
Childhood asthma is a serious public health challenge in Québec and throughout the world. Although the immune mechanisms implicated in the development of childhood asthma are not fully understood, some studies seem to suggest that the BCG vaccine, used in tuberculosis prevention, may have a protective effect on childhood asthma.
 
   Academy of Medical Sciences announces new UK-India scheme to address challenge of AMRAcademy of Medical Sciences announces new UK-India scheme to address challenge of AMR
 
The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).
 
 NTNU researchers reveal how HCV converts innocent cells into virus factories
 
NTNU researchers reveal how HCV converts innocent cells into virus factoriesThe Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus "factories" that quickly go into mass production.
 
 
 New model predicts how E. coli bacteria respond to temperature changes, genetic mutations
 
New model predicts how E. coli bacteria respond to temperature changes, genetic mutationsResearchers at the University of California San Diego have developed a genome-scale model that can accurately predict how E. coli bacteria respond to temperature changes and genetic mutations.
 
 
 CDC warns about steep rise in STDs among Americans
 
CDC warns about steep rise in STDs among AmericansAccording to a statement from the Centers for Disease Control and Prevention yesterday (26th September 2017), in 2016, a survey has revealed that more than 2 million Americans have been diagnosed with a sexually transmitted disease (STD) including infections such as gonorrhea, syphilis and Chlamydia. This is one of the highest numbers that have been detected till date they say.